50. Dermatomyositis Clinical trials / Disease details

Clinical trials : 182 / Drugs : 229 - (DrugBank : 88) / Drug target genes : 48 - Drug target pathways : 147

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02245841 (ClinicalTrials.gov)	June 15, 2015	11/9/2014	Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis	Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis	Dermatomyositis;Juvenile Dermatomyositis	Drug: H.P. Acthar Gel	The Cleveland Clinic	Mallinckrodt	Completed	18 Years	N/A	All	15	Phase 4	United States
2	NCT01906372 (ClinicalTrials.gov)	September 2013	5/7/2013	Acthar in Treatment of Refractory Dermatomyositis and Polymyositis	Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis	Dermatomyositis;Polymyositis	Drug: Adrenocorticotropic Hormone Gel	Rohit Aggarwal, MD	Mallinckrodt	Completed	18 Years	N/A	All	12	Phase 2	United States
3	NCT01637064 (ClinicalTrials.gov)	April 2013	6/7/2012	Dermatomyositis and Polymyositis Registry	Acthar Dermatomyositis and Polymyositis Treatment	Dermatomyositis;Polymyositis	Drug: Acthar	Phoenix Neurological Associates, LTD	NULL	Enrolling by invitation	18 Years	85 Years	Both	100	N/A	United States